Objective To study the clinical value of the quantities and the activity of tissue factor pathway inhibitor (TFPI) in ovarian cancer.

• 摘要目的：研究血浆组织因子途径抑制物(TFPI)抗原含量及活性对卵巢癌患者的临床意义。